Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 3/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23087047 | 1.00 | TSHR (0.48) | TSHRFAAHTRPV1EP300THRB | |
| SCHEMBL2440539 | 0.98 | — | — | |
| SCHEMBL4542428 | 0.90 | — | — | |
| SCHEMBL4421734 | 0.82 | TSHR (0.46) | TSHRFAAHTRPV1EP300THRB | |
| SCHEMBL11811524 | 0.81 | — | — | |
| SCHEMBL93548 | 0.80 | TSHR (0.52) | TSHRFAAHTRPV1EP300THRB | |
| SCHEMBL93395 | 0.80 | TSHR (0.52) | TSHRFAAHTRPV1EP300THRB | |
| SCHEMBL548516 | 0.80 | TSHR (0.52) | TSHRFAAHTRPV1EP300THRB | |
| SCHEMBL7776600 | 0.80 | TSHR (0.52) | TSHRFAAHTRPV1EP300THRB | |
| SCHEMBL39394 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1037595-A4 | SUNSCREEN CONCENTRATE | ISP INVESTMENTS INC (US) | 2001-02-14 | — | — | EP | claimed |
| CN-1279602-A | Sunscreen concentrates | ISP INVESTMENTS INC (US) | 2001-01-10 | — | — | CN | claimed |
| EP-1037595-A1 | SUNSCREEN CONCENTRATE | ISP INVESTMENTS INC. (US) | 2000-09-27 | — | — | EP | claimed |
| US-5916544-A | TITANIUM DIOXIDE OR ZINC OXIDE WITH SUNSCREEN AND DISPERSANTS | ISP INVESTMENTS INC. (US) | 1999-06-29 | — | — | US | claimed |
| WO-1999024007-A1 | SUNSCREEN CONCENTRATE | ISP INVESTMENTS INC. (US) | 1999-05-20 | — | — | WO | claimed |
| CN-117425467-A | Personal care compositions comprising silicone based | 迈图高新材料公司 | 2024-01-19 | — | — | CN | disclosed |
| US-20220212946-A1 | CERIUM (III) CARBONATE FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-07 | — | — | US | disclosed |
| US-20220125705-A1 | TOPICAL COMPOSITIONS FOR THERMAL PROTECTION AND METHODS OF MAKING THE SAME | LEARDI ENTPR LLC (US) | 2022-04-28 | — | — | US | disclosed |
| EP-3937950-A1 | TOPICAL COMPOSITIONS FOR THERMAL PROTECTION AND METHODS OF MAKING THE SAME | Leardi Enterprises, LLC (US) | 2022-01-19 | — | — | EP | disclosed |
| CN-113924077-A | Cerium (III) carbonate formulations | 加利福尼亚大学董事会 | 2022-01-11 | — | — | CN | disclosed |
| WO-2020219674-A1 | CERIUM (III) CARBONATE FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-10-29 | — | — | WO | disclosed |
| WO-2020185728-A1 | TOPICAL COMPOSITIONS FOR THERMAL PROTECTION AND METHODS OF MAKING THE SAME | LEARDI ENTERPRISES, LLC (US) | 2020-09-17 | — | — | WO | disclosed |
| WO-2001070271-A2 | ACID-STABLE BASE COMPOSITIONS FOR PREPARING SURFACTANT FREE TOPICAL COMPOSITIONS | COLLABORATIVE TECHNOLOGIES, INC. (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001070197-A2 | METHOD FOR PREPARING HIGH PRESSURE/HIGH SHEAR DISPERSIONS CONTAINING PHYSIOLOGICALLY ACTIVE INGREDIENTS | COLLABORATIVE TECHNOLOGIES, INC. (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001058238-A2 | METHOD AND SYSTEM FOR PRODUCING CUSTOMIZED COSMETIC AND PHARMACEUTICAL FORMULATIONS ON DEMAND | COLLABORATIVE TECHNOLOGIES, INC. (US) | 2001-08-16 | — | — | WO | disclosed |
| WO-2001054663-A2 | SURFACTANT FREE TOPICAL COMPOSITIONS AND METHOD FOR RAPID PREPARATION THEREOF | COLLABORATIVE TECHNOLOGIES, INC. (US) | 2001-08-02 | — | — | WO | disclosed |
| WO-2000068176-A1 | FATTY ACID ESTERS OF AROMATIC ALCOHOLS AND THEIR USE IN COSMETIC FORMULATIONS | ALZO, INC. (US) | 2000-11-16 | — | — | WO | disclosed |
| EP-1006984-A1 | MONOHYDRIC ALCOHOL DERIVED URETHANES AND THEIR USE IN COSMETIC FORMULATIONS | Alzo, Inc. (US) | 2000-06-14 | — | — | EP | disclosed |
| US-5972324-A | DIMERIC URETHANE COMPOUNDS DERIVED FROM MONOHYDRIC ALCOHOLS, GENERALLY FATTY ALCOHOLS, AND A DIISOCYANATE. | ALZO, INCO. (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1998032415-A1 | MONOHYDRIC ALCOHOL DERIVED URETHANES AND THEIR USE IN COSMETIC FORMULATIONS | ALZO, INC. (US) | 1998-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125705-A1 | TOPICAL COMPOSITIONS FOR THERMAL PROTECTION AND METHODS OF MAKING THE SAME | ANXA3, MLEC, PHOSPHO1 | TSHR 4489/4885FAAH 1929/4885TRPV1 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.